SEC Form 4 · accession 0001209191-16-113634
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Essig
Director
Period of report
Apr 6, 2016
Accepted (ET)
Apr 7, 2016 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 6, 2016 | M | 21,100 | $36.80 | A | 981,419 | D | |
| Common StockF2 | Apr 6, 2016 | S | 21,100 | $66.1858 | D | 960,319 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $36.80 | Apr 6, 2016 | M | 21,100 | D | — | Dec 19, 2016 | Common Stock | 21,100 | 104,390 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F2The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $65.79 to $66.61.
- F325% of the option grant vested on 12/19/2007 (the first anniversary of the grant date of 12/19/2006), and the remaining 75% vested monthly thereafter over 36 months.